Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v5-FR
Language English French
Date Updated 2017-08-11 2017-08-02
Drug Identification Number 02323052 02323052
Brand name INSPRA INSPRA
Common or Proper name Inspra Inspra
Company Name BGP PHARMA ULC BGP PHARMA ULC
Ingredients EPLERENONE EPLERENONE
Strength(s) 25MG 25MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 3 x 10 TABS 3 x 10 TABS
ATC code C03DA C03DA
ATC description POTASSIUM-SPARING AGENTS POTASSIUM-SPARING AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-07-20 2017-07-20
Actual start date
Estimated end date 2017-08-10 2017-08-07
Actual end date 2017-08-10
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Resolved August 10, 2017. Product currently under allocation Product currently under allocation
Health Canada comments